High yield and antimalarial Artemisia annua trial in Kenya

In erdoret and killeli, Kenya, an improved antimalarial medicinal plant Artemisia annua is about to harvest The scientists hope that the Artemisia annua can be planted and produced as expected in Africa to meet the growing global demand for raw materials for antimalarial drugs Artemisia annua is the main raw material of artemisinin, but there is a shortage of artemisinin which can be effectively extracted in the international medical community Six months ago, scientists at the University of York in the UK began planting the improved Artemisia annua at the two sites Kenya's flag newspaper recently reported that the Artemisia annua are now two meters high, with luxuriant branches and leaves and good growth It is expected to harvest next month The University of York measured the genome map of Artemisia annua earlier this year Elspis Bartlett, a press officer at the new crop center of the University's AI plant research and engineering, said they have adopted the latest genetic engineering technology in the hope of developing new varieties of Artemisia annua with high yield but no transgene Bartlett said that once the concentration of artemisinin in the new variety is higher than 0.8%, it can be regarded as a breakthrough in the experiment Bartlett also told the banner that they had conducted similar experiments in Uganda, Madagascar, India and China According to reports, artemisinin is currently the most effective drug for malaria treatment, which is mainly extracted from Artemisia annua.